作者： Yang, Minghui¹;Li, Chunhui¹;Ye, Guoguo²;Shen, Chenguang³;Shi, Huiping¹;Zhong, Liping⁴;Tian, Yuxin¹;Zhao, Mengyuan¹;Wu, Pengfei¹;Hussain, Abid¹;Zhang, Tian¹;Yang, Haiyin¹;Yang, Jun¹;Weng, Yuhua¹;Liu, Xinyue¹;Wang, Zhimin¹;Gan, Lu⁴;Zhang, Qianyu⁴;Liu, Yingxia²;Yang, Ge⁵;Huang, Yuanyu¹;Zhao, Yongxiang⁴ （¹Beijing Inst Technol, Adv Res Inst Multidisciplinary Sci, Sch Life Sci, Key Lab Mol Med & Biotherapy, Beijing 100081, Peoples R China.;²Southern Univ Sci & Technol, Shenzhen Peoples Hosp 3, Natl Clin Res Ctr Infect Dis, Affiliated Hosp 2, Shenzhen 518112, Peoples R China.;³Southern Med Univ, Sch Publ Hlth, Guangdong Prov Key Lab Trop Dis Res, Guangzhou 510515, Peoples R China.;⁴Guangxi Med Univ, Natl Ctr Int Res Biotargeting Theranost, Collaborat Innovat Ctr Targeting Tumor Diag & Ther, State Key Lab Targeting Oncol,Guangxi Key Lab Biot, Nanning 530021, Peoples R China.;⁵Chinese Acad Med Sci & Peking Union Med Coll, Inst Med Biotechnol, Beijing Key Lab Antimicrobial Agents, CAMS Key Lab Antiviral Drug Res, Beijing 100730, Peoples R China.）

出处： SIGNAL TRANSDUCTION AND TARGETED THERAPY 2024 Vol.9 No.1

关键词： ACUTE RESPIRATORY SYNDROME; GROWTH-FACTOR THERAPY; DIMERIZATION DOMAIN; DNA APTAMERS; FACTOR-B; RNA; INHIBITION; OLIGOMERIZATION; AS1411

摘要： Emerging and recurrent infectious diseases caused by human coronaviruses (HCoVs) continue to pose a significant threat to global public health securit ...

作者： Tian, Yuxin¹;Li, Mengjun²;Yang, Yang³;Li, Chunhui¹;Peng, Yun³;Yang, Haiyin¹;Zhao, Mengyuan¹;Wu, Pengfei¹;Ruan, Shaobo¹;Huang, Yuanyu¹;Shen, Chenguang²;Yang, Minghui¹ （¹Beijing Inst Technol, Sch Life Sci, Adv Res Inst Multidisciplinary Sci, Key Lab Mol Med & Biotherapy, Beijing 100081, Peoples R China.;²Southern Med Univ, BSL 3 Lab Guangdong, Guangdong Prov Key Lab Trop Dis Res, Sch Publ Hlth,Dept Lab Med, Guangzhou 510280, Peoples R China.;³Southern Univ Sci & Technol, Shenzhen Peoples Hosp 3, Natl Clin Res Ctr Infect Dis, Affiliated Hosp 2, Shenzhen 518112, Peoples R China.）

出处： CHINESE CHEMICAL LETTERS 2024 Vol.35 No.8

关键词： ATTENUATED SMALLPOX VACCINE; PROTEINS

摘要： The monkeypox virus (MPXV) outbreak, declared a Public Health Emergency of International Concern (PHEIC) by the World Health Organization (WHO) in 202 ...

发明人： 杨明辉，叶国国，黄渊余，李春辉

申请人： 北京理工大学

申请号： 202310446087.4

申请日期： 2023.04.23

摘要： 本发明涉及能特异性抑制寨卡病毒(ZIKV)、登革病毒(DENV)及黄热病毒(YFV)等黄病毒属感染的多肽以及药物组合物。本发明提供的该多肽包括寨卡病毒的衣壳蛋白或其片段，所述片段与寨卡病毒的衣壳蛋白二聚体结合。这对于黄病毒属感染的治疗，尤其是孕妇ZIKV感染的治疗显得尤为重要，可以作为预防或治疗ZI ...

发明人： 杨明辉，黄渊余，沈晨光，叶国国，李春辉，石慧萍，田雨欣，赵梦圆

申请人： 北京理工大学

申请号： 202310651358.X

申请日期： 2023.06.02

摘要： 本文提供了冠状病毒mRNA疫苗及其应用。本文的核酸分子编码能够引发针对冠状病毒的强效中和抗体反应的高免疫原性抗原，用于表达冠状病毒刺突(S)蛋白的关键中和结构域，当单独或组合用作免疫原性组合物或疫苗时，能有效诱导保护性免疫。

发明人： 杨明辉，叶国国，李春辉，黄渊余，赵梦圆，田雨欣

申请人： 北京理工大学

申请号： 202310587541.8

申请日期： 2023.05.23

摘要： 本公开涉及特异性结合冠状病毒核衣壳蛋白的核酸适配体。本公开的核酸适配体可以与冠状病毒核衣壳蛋白以高亲和力特异性结合，能够快速、高效的进入细胞发挥作用，并在较长时间内均可有效抑制冠状病毒的病毒复制与增殖；同时，本公开的核酸适配体在细胞内具有较好的安全性，是潜在的冠状病毒预防和治疗药物。

作者： Ren, Sizhu¹; Li, Chunhui¹

出处： 2022 Chinese Automation Congress, CAC 2022 Xiamen, China 2022

会议录： Vol.Vol.2022-January 2217-2220

作者： Li Chunhui¹;Yang Tongren¹;Weng Yuhua¹;Zhang Mengjie¹;Zhao Deyao^1,2;Guo Shuai¹;Hu Bo¹;Shao Wanxuan¹;Wang Xiaoxia³;Hussain Abid^1,4;Liang Xingjie⁵;Huang Yuanyu^1,6 （¹School of Life Science, Advanced Research Institute of Multidisciplinary Science, Institute of Engineering Medicine, Key Laboratory of Molecular Medicine and Biotherapy, Beijing Institute of Technology, Beijing, 100081;²Department of Radiation Oncology, The First Affiliat, Zhengzhou, 450000;³Institute of Molecular Medicine, College of Future Technology, Peking University, Beijing, 100871;⁴National Center for Nanoscience and Technology of Ch, Chinese Academy of Sciences (CAS) Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety;;CAS Center for Excellence in Nanoscience, Beijing, 100190;⁵National Center for Nanoscience and Technology of China, Chinese Academy of Sciences (CAS) Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety;;CAS Center for Excellence in Nanoscience, Beijing, 100190;⁶School of Materials and the Environment, Beijing Ins, Zhuhai, 519085）

出处： Bioactive Materials 2022 第9卷 第期 P590-601

关键词： CRISPR/Cas；Gene editing；Lipid nanoparticle；PLK1；Cancer therapy

摘要： CRISPR/Cas9-based gene editing has emerged as a powerful biotechnological tool, that relies on Cas9 protein and single guided RNA (sgRNA) to edit targ ...

作者： Chanchan Yu，Kun Li，Lin Xu，Bo Li，Chunhui Li，Shuai Guo，Ziyue Li，Yuquan Zhang，Abid Hussain，Hong Tan，Mengyu Zhang，Yongxiang Zhao，Yuanyu Huang，Xing-Jie Liang （School of Life Science，Advanced Research Institute of Multidisciplinary Science，School of Medical Technology(Institute of Engineering Medicine)，Key Laboratory of Molecular Medicine and Biotherapy，Key Laboratory of Medical Molecule Science and Pharmaceutics Engineering，Beijing Institute of Technology，Beijing 100081，China；CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety，CAS Center for Excellence in Nanoscience，National Center for Nanoscience and Technology of China，Beijing 100190，China；School of Life Science，Advanced Research Institute of Multidisciplinary Science，School of Medical Technology(Institute of Engineering Medicine)，Key Laboratory of Molecular Medicine and Biotherapy，Key Laboratory of Medical Molecule Science and Pharmaceutics Engineering，Beijing Institute of Technology，Beijing 100081，China；National Center for International Research of Biological Targeting Diagnosis and Therapy，Guangxi Key Laboratory of Biological Targeting Diagnosis and Therapy Research，Guangxi Medical University，Nanning530021，China；CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety，CAS Center for Excellence in Nanoscience，National Center for Nanoscience and Technology of China，Beijing 100190，China）

出处： 纳米研究(英文版) 2022 第15卷 第10期 P9160-9168

关键词： coordination；chemistry；nuclei；acid；lanthanide；nanomaterials；small；interfering；RNA(siRNA)delivery；endosome；escape

摘要： Attaching DNA/RNA to nanomaterials is the basis for nucleic acid-based assembly and drug delivery.Herein,we report that small interfering RNA(siRNA)ef ...

作者： Li, Chunhui^1,2;Zou, Hengguang³;Shi, Dawei^1,2;Song, Jiliang^1,2;Wang, Junzheng^1,2; （¹ Beijing Inst Technol, State Key Lab Intelligent Control & Decis Complex, Beijing 100081, Peoples R China. ;² Beijing Inst Technol, Sch Automat, Beijing 100081, Peoples R China. ;³ China Acad Space Technol, Beijing 100094, Peoples R China.）

出处： IEEE TRANSACTIONS ON AEROSPACE AND ELECTRONIC SYSTEMS 2022 Vol.58 No.4 P3021-3036

关键词： SLIDING MODE CONTROL; DISTURBANCE REJECTION; COORDINATION CONTROL; SPACECRAFT; OBSERVER; SYSTEMS; MOTION

摘要： This article aims to investigate the coupled attitude and orbit tracking control problem of rigid spacecraft motion. A proportional-integral (PI)-type ...

作者： Hu, Bo¹;Li, Bo¹²;Li, Kun¹;Liu, Yuanyuan¹³;Li, Chunhui¹;Zheng, Lulu¹;Zhang, Mengjie¹;Yang, Tongren¹;Guo, Shuai¹;Dong, Xiyu³;Zhang, Tian¹;Liu, Qing¹;Hussain, Abid¹;Weng, Yuhua¹;Peng, Ling⁴;Zhao, Yongxiang⁵;Liang, Xingjie⁶;Huang, Yuanyu¹; （¹School of Life Science, Advanced Research Institute of Multidisciplinary Science, Institute of Engineering Medicine, Key Laboratory of Molecular Medicine and Bio-therapy, Key Laboratory of Medical Molecule Science and Pharmaceutics Engineering, Beijing Institute of Technology, Beijing, 100081, China;²Beijing Key Laboratory for Separation and Analysis in Biomedicine and Pharmaceuticals, Beijing Institute of Technology, Beijing, 100081, China;³School of Chemistry and Chemical Engineering, Beijing Institute of Technology, Beijing, 100081, China;⁴Aix-Marseille Université, Center Interdisciplinaire de Nanoscience de Marseille, UMR 7325, Equipe Labellisée Ligue Contre le Cancer, CNRS, Marseille, France;⁵National Center for International Research of Biological Targeting Diagnosis and Therapy, Guangxi Key Laboratory of Biological Targeting Diagnosis and Therapy Research, Guangxi Medical University, Guangxi, Nanning, 530021, China;⁶Chinese Academy of Sciences (CAS), Center for Excellence in Nanoscience, CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology, Beijing, 100190, China）

出处： Science Advances 2022 Vol.8 No.7

摘要： Small interfering RNA (siRNA) therapeutic is considered to be a promising modality for the treatment of hyperlipidemia. Establishment of a thermostabl ...